DFA's Streamlining Screening of Pregnant Women During ANC named an awardee in the Saving Lives at Birth competition for seed grant funding.
Cambridge, MA -- On Wednesday, July 22, Saving Lives at Birth: A Grand Challenge for Development announced Diagnostics For All as one of 17 grant nominees to receive $250,000 in seed grant funding for Streamlining the Screening of Pregnant Women During ANC. DFA's Senior Scientist, Christina Swanson, presented at the DevelopmentXChange in Washington, DC on July 22 as one of 53 finalists, who each had "the opportunity to present their innovations in a dynamic open marketplace, and exchange ideas with development experts and potential funders."
Through this seed grant, DFA will develop a sensitive, low-cost, rapid, paper-based microfluidic diagnostic test to screen pregnant women for anemia, HIV, HBV, and syphilis, from one drop of blood. The ANC Panel will ensure that women who attend ANC at least once are tested for the most critical diseases and provided results on the spot. DFA’s ANC Panel could improve maternal and child health outcomes for up to 31 million pregnant women in the developing world and their children.
About Diagnostics For All
Incorporated in 2007, Diagnostics For All is a 501(c)(3) non-profit enterprise creating low-cost, easy-to-use point-of-care diagnostics specifically designed for the developing world. These devices are elegantly simple and inexpensive. They require minimal training to use, minimal sample preparation, and no electricity or additional equipment. For more information, visit www.dfa.org or email email@example.com.